Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.10.0.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
CURRENT ASSETS    
Cash and cash equivalents $ 1,206 $ 9,541
Accounts receivable, net of allowance for doubtful accounts of 2018 $7,967; 2017 $6,539 8,981 10,958
Other current assets 2,928 2,707
Total current assets 13,115 23,206
FIXED ASSETS, net of accumulated depreciation 4,499 5,550
OTHER ASSETS    
Restricted cash 350 350
Patents and other intangible assets, net of accumulated amortization 4,121 4,478
Investment in joint venture 242 246
Goodwill 17,257 17,992
Other 301 399
Total other assets 22,271 23,465
Total Assets 39,885 52,221
CURRENT LIABILITIES    
Accounts payable and accrued expenses 13,040 8,715
Obligations under capital leases, current portion 324 272
Deferred revenue 2,409 516
Line of credit 2,764 4,137
Term note 6,000 6,000
Convertible note, net 2,302 0
Advance from NovellusDx, Ltd. 1,500 0
Total current liabilities 28,339 19,640
Obligations under capital leases 451 624
Deferred rent payable and other 283 360
Warrant liability 1,122 4,403
Deferred revenue, long-term 442 429
Total Liabilities 30,637 25,456
STOCKHOLDERS’ EQUITY    
Preferred stock, authorized 9,764 shares, $0.0001 par value, none issued 0 0
Common stock, authorized 100,000 shares, $0.0001 par value, 27,726 and 27,754 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively 3 3
Additional paid-in capital 163,092 161,527
Accumulated other comprehensive income 104 69
Accumulated (deficit) (153,951) (134,834)
Total Stockholders’ Equity 9,248 26,765
Total Liabilities and Stockholders’ Equity $ 39,885 $ 52,221